A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children
Clinical trial NCT02207413 · COMPLETED
Trial details
- NCT number
- NCT02207413
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-18
- Primary completion
- 2015-04-18
- Enrollment
- 1886
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.